Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity-Reference-Cited by-同舟云学术

Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity

Published:2017-12 Issue:24 Volume:70 Page:3072
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Anastasiou Maria,Oikonomou Evangelos,Zagouri Flora,Siasos Gerasimos,Antonopoulos Alexios S.,Psaltopoulou Theodora,Bamias Aristotelis,Dimopoulos Meletios A.,Tousoulis Dimitris

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference2 articles.

1. Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer;Finkelman;J Am Coll Cardiol,2017

2. Inorganic nitrate therapy improves doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone?;Daiber;J Am Coll Cardiol,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients;Vascular Pharmacology;2023-10

2. Efficacy of exercise training for improving vascular dysfunction in people with cancer: a systematic review with meta-analyses;Journal of Cancer Survivorship;2023-04-20

3. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure;International Journal of Molecular Sciences;2023-02-21

4. A bench to bedside perspective on anthracycline chemotherapy-mediated cardiovascular dysfunction: challenges and opportunities. A symposium review;Journal of Applied Physiology;2022-12-01

5. Endothelial dysfunction as a complication of anti-cancer therapy;Pharmacology & Therapeutics;2022-09